3647 results for «545»
3647 results
First-in-man and out-of-the-box innovations hotline
15 May 2024 – From EuroPCR 2024
This session showcases a variety of first-in-man and innovative technologies in the field of interventional cardiology. Presentations will cover topics such as NeuroOCT (nOCT) for intracranial imaging, the BackBeat system for atrio-ventricular interval modulation, renal stimulation with direct wire pacing, the TIVUS system for renal denervation,...
TAVI: procedural complications - Part 2
16 May 2024 – From EuroPCR 2024
This session focuses on the management of procedural complications during transcatheter aortic valve implantation (TAVI). It presents a series of challenging cases, including valve-in-valve TAVI with complications, acute cardiogenic shock during valve-in-valve TAVI, and various other complications such as left ventricular perforation, fistula formation, and lost...
New frontiers in coronary physiology and imaging
15 May 2024 – From EuroPCR 2024
When mitral valve intervention goes wrong
16 May 2024 – From EuroPCR 2024
This session examines various complications that can arise during mitral valve interventions, such as iatrogenic aortic root perforation, unexpected leakage, and other challenging scenarios. The presenters share their experiences in managing these complications and the strategies they employed to address them. The session emphasizes the importance...
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Author